Skip to main content
Curocell Inc. logo

Curocell Inc. — Investor Relations & Filings

Ticker · 372320 ISIN · KR7372320002 KO Manufacturing
Open in API
Filings indexed 109 across all filing types
Latest filing 2025-03-26 Declaration of Voting R…
Country KR South Korea
Listing KO 372320

About Curocell Inc.

https://curocellbtx.com/

Curocell Inc. is a clinical-stage biotechnology company specializing in the development of Chimeric Antigen Receptor T-cell (CAR-T) therapies. The company focuses on engineering a patient's own immune cells to recognize and eliminate cancer, primarily targeting blood cancers. Curocell's proprietary OVIS™ technology is an immune checkpoint receptor platform designed to enhance the efficacy of CAR-T treatments by overcoming the immunosuppressive tumor microenvironment. The company has advanced its lead candidate, anbalcabtagene autoleucel (Limkato), through Phase 2 clinical trials and operates a state-of-the-art GMP facility for the production of its advanced cell therapies.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting held on 2025-03-26, including financial statement approval, director/auditor compensation limits, and stock option grants. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from the company Curocell. It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the current and previous fiscal years, as required by Korean regulatory standards (DART). While it contains financial data, it is a summary announcement of the audit results rather than the full, multi-page annual report (10-K) or a standalone audit report (AR). In the context of Korean regulatory filings, this specific format is a standard disclosure announcement regarding the receipt and submission of the audit report, which falls under the 'Regulatory Filings' category as a general announcement. FY 2024
2025-03-14 Korean
사업보고서 (2024.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the company 'Curocell' (주식회사 큐로셀) for the fiscal year 2024. It contains detailed sections including company overview, history, capital changes, and business operations. In the South Korean regulatory context, the 'Business Report' (사업보고서) is the equivalent of the US 10-K, serving as the comprehensive annual financial and operational disclosure filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2024
2025-03-14 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 1% confidence The document is a 'Correction Report' (정정신고) for a Business Report (사업보고서) filed by Curocell. It explicitly details corrections made to the 'Notes to Consolidated Financial Statements' (연결재무제표 주석) and provides substantive financial data, accounting policies, and financial information for the fiscal year ending December 31, 2024. Since it contains comprehensive financial statements and detailed notes, it falls under the category of an Interim/Quarterly or Annual Report. Given the context of a 'Business Report' (which is the Korean equivalent of a 10-K), it is classified as a 10-K. FY 2024
2025-03-14 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Curocell. It outlines the date, time, location, and agenda items (such as financial statement approval and director compensation). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2025-03-10 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Curocell. It contains the meeting agenda, details on voting, and management information regarding the company's business and financial status. In the context of financial filings, this type of document is classified as a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on resolutions at the upcoming Annual General Meeting.
2025-03-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.